Exclusive: Cancer drugmaker Tesaro attracts takeover interest - sources

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. NDAQ

Go back to Exclusive: Cancer drugmaker Tesaro attracts takeover interest - sources

Leerink Partners Downgrades Tesaro (TSRO) to Market Perform

February 10, 2017 6:51 AM EST

Leerink Partners downgraded Tesaro (NASDAQ: TSRO) from Outperform to Market Perform with a price target of $186.00 (from $152.00).

For an analyst ratings summary and ratings history on Tesaro click here. For more ratings news on Tesaro click here.

Shares of Tesaro closed at $186.91 yesterday.

... More

TESARO (TSRO) may be worth $250/share in sale, Bloomberg citing SunTrust

February 8, 2017 1:07 PM EST

TESARO (NASDAQ: TSRO) may be worth $250/share in sale, Bloomberg citing SunTrust.

... More